Clinical trial
Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable…
NCT00386984 · University Hospital Freiburg, Other · Completed
Key facts
| NCT number | NCT00386984 |
|---|---|
| Title | Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma |
| Official title | Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma |
| Lead sponsor | University Hospital Freiburg, Other |
| Collaborators | German Federal Ministry of Education and Research Deutsche Krebshilfe e.V., Bonn (Germany) Novartis Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma, Hepatocellular |
| Intervention type | Drug |
| Interventions | Somatostatin (octreotide) |
| Enrollment | 108 |
| Start date | Oct 1, 1999 |
| Completion | Feb 1, 2003 |
| First posted | Oct 12, 2006 |
| Last update posted | Oct 12, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: